Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Apply
Obrixtamig & ZL-1310
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step